FindTrial
Sign In

SUPRAFYSIOLOGINEN HYDROKORTISONI VAIKEASSA AKUUTISSA HAIMATULEHDUKSESSA - HC-SAP

SUPRAFYSIOLOGINEN HYDROKORTISONI VAIKEASSA AKUUTISSA HAIMATULEHDUKSESSA - HC-SAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-002346-30-FI
Enrollment
Unknown
Registered
2008-06-18
Start date
2008-10-03
Completion date
Unknown
Last updated
2014-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaikea akuutti haimatulehdus, johon liittyy verenkiertovajaus MedDRA version: 9.1 Level: LLT Classification code 10000971 Term: Acute pancreatitis

Interventions

Trade Name: Solu-Cortef Pharmaceutical Form: INN or Proposed INN: HYDROCORTISONE SODIUM SUCCINATE CAS Number: 125042 Pharmaceutical form of the placebo: Intravenous infusion Route of administration o

Sponsors

Esko Kemppainen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026